EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mutational analysis of an antimalarial drug target, Pf ATP4

Swaksha Rachuri iD, Binod Nepal, Anurag Shukla iD, Aarti Ramanathan, Joanne M Morrisey iD, Thomas Daly, Michael W Mather iD, Lawrence W Bergman, Sandhya Kortagere iD, Akhil B Vaidya iD

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2403689122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Swaksha Rachuri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Center for Molecular Parasitology, Drexel University College of Medicine, Philadelphia, PA 19129. Hauptthemen laut MEDLINE: Plasmodium falciparum, Antimalarials. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), NIAID NIH HHS, HHS | NIH | National Institute of General Medical Sciences (NIGMS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among new antimalarials discovered over the past decade are multiple chemical scaffolds that target Plasmodium falciparum P-type ATPase ( Pf ATP4). This essential protein is a Na + pump responsible for the maintenance of Na + homeostasis. Pf ATP4 belongs to the type 2D subfamily of P-type ATPases, for which no structures have been determined. To gain better insight into the structure/function relationship of this validated drug target, we generated a homology model of Pf ATP4 based on sarco/endoplasmic reticulum Ca 2+ ATPase, a P2A-type ATPase, and refined the model using molecular dynamics in its explicit membrane environment. This model predicted several residues in Pf ATP4 critical for its function, as well as those that impart resistance to various Pf ATP4 inhibitors. To validate our model, we developed a genetic system involving merodiploid states of Pf ATP4 in which the endogenous gene was conditionally expressed, and the second allele was mutated to assess its effect on the parasite. Our model predicted residues involved in Na + coordination as well as the phosphorylation cycle of Pf ATP4. Phenotypic characterization of these mutants involved assessment of parasite growth, localization of mutated Pf ATP4, response to treatment with known Pf ATP4 inhibitors, and evaluation of the downstream consequences of Na + influx. Our results were consistent with modeled predictions of the essentiality of the critical residues. Additionally, our approach confirmed the phenotypic consequences of resistance-associated mutations as well as a potential structural basis for the fitness cost associated with some mutations. Taken together, our approach provides a means to explore the structure/function relationship of essential genes in haploid organisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumAntimalarialsProtozoan ProteinsDNA Mutational AnalysisDrug ResistanceModels, MolecularHumansMalaria, FalciparumMolecular Dynamics SimulationP-type ATPasesMutationCalcium-Transporting ATPases

Stichwörter der Autor:innen

P-type ATPasesantimalarial drugsmalariamolecular dynamicsmutagenesis

Substanzen

AntimalarialsProtozoan ProteinsP-type ATPasesCalcium-Transporting ATPases

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Center for Molecular Parasitology, Drexel University College of Medicine, Philadelphia, PA 19129.

ORCID-Profile: Swaksha Rachuri, Anurag Shukla, Joanne M Morrisey, Michael W Mather, Sandhya Kortagere, Akhil B Vaidya

Förderung

  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • NIAID NIH HHS
  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)
  • Anton 2 Award
  • NIGMS NIH HHS

Zitieren

APA

Rachuri, S., Nepal, B., Shukla, A., Ramanathan, A., Morrisey, J. M., Daly, T., Mather, M. W., Bergman, L. W., Kortagere, S., & Vaidya, A. B. (2025). Mutational analysis of an antimalarial drug target, Pf ATP4. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2403689122

Vancouver

Rachuri S, Nepal B, Shukla A, Ramanathan A, Morrisey JM, Daly T, et al. Mutational analysis of an antimalarial drug target, Pf ATP4. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2403689122

BibTeX
@article{Rachuri2025,
  author = {Rachuri, Swaksha and Nepal, Binod and Shukla, Anurag and Ramanathan, Aarti and Morrisey, Joanne M and Daly, Thomas and Mather, Michael W and Bergman, Lawrence W and Kortagere, Sandhya and Vaidya, Akhil B},
  title = {Mutational analysis of an antimalarial drug target, Pf ATP4},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2403689122}
}
Kostenlos starten →